Türkiye has taken a significant step in healthcare regulation by legalizing the controlled use and sale of medical cannabis-based products. The new law, adopted by the Grand National Assembly, introduces a structured and highly regulated system governing the production, processing, and distribution of cannabis-derived medical products.
For foreign investors, healthcare professionals, and patients, this development marks both a legal transformation and a new regulated market opportunity.
This guide prepared by Bayraktar Attorneys explains what has changed, how the system will operate, and what this means in practice.
What Has Changed with the New Law?
The law titled “Amendments to Certain Health-Related Laws and Decree Law No. 663” introduces a legal framework allowing medical cannabis products to be sold through pharmacies in Türkiye.
This does not mean that cannabis has been broadly legalized.
Instead, the regulation clearly distinguishes between:
Medical cannabis products(regulated, licensed, pharmaceutical use)
Narcotic cannabis (illegal use)
Only products approved and controlled by the authorities will be permitted.
Which Authorities Are Responsible?
The system is divided between two main ministries:
Ministry of Agriculture and Forestry
Responsible for cultivation and harvesting of cannabis
Controls agricultural production processes
Ministry of Health
Responsible for processing, licensing, and product approval
Oversees distribution, sales, and safety
Manages electronic tracking systems
This dual structure ensures full control from production to patient delivery.
How Will Medical Cannabis Be Sold?
The law introduces a strict distribution model:
Sales will be allowed only through licensed pharmacies
Products will require official approval and licensing
Distribution will be monitored via an electronic tracking system
This means:
No over-the-counter or uncontrolled sales
No retail or commercial free-market distribution
Full traceability of every product
What Is Medical Cannabis?
Cannabis contains a psychoactive component known as THC (tetrahydrocannabinol).
Under the new framework:
Cannabis with THC levels below 0.3%is generally considered low-THC
Low-THC products do not produce narcotic effects
These products are used strictly for medical purposes
Medical cannabis is commonly used internationally for:
Chronic pain management
Cancer-related treatments
Neurological conditions such as multiple sclerosis (MS)
Certain psychiatric or neurological symptoms
It is important to emphasize that these products are pharmaceutical in nature, not recreational substances.
Global Context: Is Türkiye Following an International Trend?
Yes. Many countries have already implemented similar frameworks.
Examples include:
Germany
Canada
Israel
Australia
Netherlands
Italy
In most of these jurisdictions:
Medical cannabis is strictly regulated
Distribution is often limited to pharmacies or licensed channels
Patient access is controlled through prescriptions and monitoring systems
Türkiye’s model aligns with this global regulatory approach.
Why Is This Regulation Important?
This reform has several key implications:
Patient Access
Patients who previously had to import medical cannabis products may now access them more easily through domestic systems.
Regulatory Control
The state maintains full control over:
Production
Distribution
Usage
Market Development
The law opens the door for:
Pharmaceutical investments
Controlled agricultural production
Export opportunities
What Do Pharmacists and Experts Say?
Healthcare professionals generally support the regulation, provided that strict control mechanisms remain in place.
Key points highlighted by experts include:
Medical cannabis is already used internationally
Pharmacy-based distribution ensures safety
Electronic tracking systems prevent misuse
Proper regulation is essential to avoid abuse
There is also emphasis on the fact that many existing pharmaceutical products can be misused, and cannabis-based medicines should be treated similarly under strict control.
Legal Distinction: Medical Product vs. Narcotic Substance
One of the most critical aspects of the new law is the clear legal distinction between:
Licensed medical cannabis products
Illegal narcotic cannabis
This distinction will be crucial in:
Criminal law enforcement
Prescription practices
Regulatory compliance
Any product outside the approved system will continue to fall under strict criminal regulations.
What Does This Mean for Foreign Investors?
From a legal and commercial perspective, this regulation creates a controlled but promising sector.
Potential opportunities include:
Pharmaceutical manufacturing
Licensed distribution partnerships
Agricultural production under government authorization
Export-oriented production models
However, entry into this market will require:
Strict compliance with licensing requirements
Regulatory approvals from multiple authorities
Ongoing monitoring and reporting
Conclusion
The legalization of medical cannabis in Türkiye does not represent a relaxation of drug laws. Instead, it introduces a highly controlled medical framework aligned with international standards.
Key takeaways:
Medical cannabis is now legal under strict conditions
Sales are limited to licensed pharmacies
Production and distribution are fully regulated
The system is designed to balance patient access and public safety
For both patients and investors, the new framework offers opportunities, but only within a strict legal structure.
At Bayraktar Attorneys, we assist clients in navigating regulated sectors such as pharmaceuticals, healthcare compliance, and investment structuring in Türkiye.
Recently Added Blogs
